Summary
Stryker Corporation (SYK) announced on August 1, 2017, the election of Mary K. Brainerd to its Board of Directors, effective as of July 31, 2017. Ms. Brainerd brings extensive experience in the healthcare industry, having most recently served as president and chief executive officer of HealthPartners, a large non-profit health care organization, for 15 years. Her background includes leadership roles across various healthcare entities and experience on other public company boards, which should provide valuable strategic oversight for Stryker. As a new non-employee director, Ms. Brainerd will receive compensation in line with Stryker's standard director pay practices, including annual fees and equity awards. Notably, the filing discloses that Stryker sells products to HealthPartners in the ordinary course of business, with approximately $17 million in sales between January 1, 2016, and May 31, 2017. This disclosure is important for transparency regarding potential related-party transactions, although it appears to be within normal business operations.
Key Highlights
- 1Mary K. Brainerd elected to the Board of Directors.
- 2Ms. Brainerd has 15 years of experience as president and CEO of HealthPartners, a major non-profit healthcare organization.
- 3Her background includes executive roles in healthcare and prior board experience with other public companies (Possis Medical, SurModics).
- 4Ms. Brainerd will receive standard non-employee director compensation, including annual fees and equity awards (stock options and RSUs).
- 5She received an initial equity award including 3,005 stock options and 600 restricted stock units.
- 6The filing discloses ordinary course business sales from Stryker to HealthPartners totaling approximately $17 million from Jan 2016 to May 2017.
- 7There are no undisclosed arrangements or understandings related to Ms. Brainerd's selection.